DF6227-FAM3B Antibody

Total Page：16

File Type：pdf, Size：1020Kb

Affinity Biosciences website:www.affbiotech.com order:[email protected] FAM3B Antibody Cat.#: DF6227 Concn.: 1mg/ml Mol.Wt.: 26kDa Size: 100ul,200ul Source: Rabbit Clonality: Polyclonal Application: WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000 *The optimal dilutions should be determined by the end user. Reactivity: Human,Mouse,Rat Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific). Specificity: FAM3B Antibody detects endogenous levels of total FAM3B. Immunogen: A synthesized peptide derived from human FAM3B, corresponding to a region within C-terminal amino acids. Uniprot: P58499 Description: FAM3B (family with sequence similarity 3, member B), also known as ORF9, C21orf11 or PANDER, is a 235 amino acid secreted protein that localizes to discrete vesicular and perinuclear structures. Expressed at high levels in pancreas and at lower levels in kidney, colon, testis, prostate and small intestine, FAM3B functions as an islet-specific cytokine that promotes apoptosis and may inhibit Insulin secretion from beta-cells, possibly playing a role in overall pancreatic activity. Human FAM3B shares 78% sequence identity with its mouse counterpart, suggesting a conserved role between species. Three isoforms of FAM3B, designated A, B and C, exist due to alternative splicing events. The gene encoding FAM3B maps to human chromosome 21, which houses approximately 300 genes and comprises nearly 1.5% of the human genome. Storage Condition and Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM Buffer: NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt. 1 / 2 Affinity Biosciences website:www.affbiotech.com order:[email protected] Western blot analysis of PC-3 lysates using FAM3B antibody. The lane on the left was treated with the antigen-specific peptide. DF6227 at 1/100 staining Mouse testis tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody. IMPORTANT: For western blot, incubate membrane with diluted primary Ab in 5% w/v milk , 1X TBS, 0.1% Tween®20 at 4°C with gentle shaking, overnight. For Research Use Only. Not for use in diagnostic and therapeutic procedures. Not for resale without express authorization. 2 / 2 Powered by TCPDF (www.tcpdf.org).

Copy Link

Recommended publications

Primate Specific Retrotransposons, Svas, in the Evolution of Networks That Alter Brain Function
Title: Primate specific retrotransposons, SVAs, in the evolution of networks that alter brain function. Olga Vasieva1*, Sultan Cetiner1, Abigail Savage2, Gerald G. Schumann3, Vivien J Bubb2, John P Quinn2*, 1 Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, U.K 2 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK 3 Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, D-63225 Germany *. Corresponding author Olga Vasieva: Institute of Integrative Biology, Department of Comparative genomics, University of Liverpool, Liverpool, L69 7ZB, [email protected] ; Tel: (+44) 151 795 4456; FAX:(+44) 151 795 4406 John Quinn: Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK, [email protected]; Tel: (+44) 151 794 5498. Key words: SVA, trans-mobilisation, behaviour, brain, evolution, psychiatric disorders 1 Abstract The hominid-specific non-LTR retrotransposon termed SINE–VNTR–Alu (SVA) is the youngest of the transposable elements in the human genome. The propagation of the most ancient SVA type A took place about 13.5 Myrs ago, and the youngest SVA types appeared in the human genome after the chimpanzee divergence. Functional enrichment analysis of genes associated with SVA insertions demonstrated their strong link to multiple ontological categories attributed to brain function and the disorders. SVA types that expanded their presence in the human genome at different stages of hominoid life history were also associated with progressively evolving behavioural features that indicated a potential impact of SVA propagation on a cognitive ability of a modern human.
[Show full text]
The Cytokine FAM3B/PANDER Is an FGFR Ligand That Promotes Posterior Development in Xenopus
The cytokine FAM3B/PANDER is an FGFR ligand that promotes posterior development in Xenopus Fangfang Zhanga,b,1, Xuechen Zhuc,d,1, Pan Wange,f,1, Qing Hea,b, Huimei Huangg, Tianrui Zhengf, Yongyu Lif, Hong Jiab, Linping Xub, Huaxiang Zhaoh, Gabriele Colozzai, Qinghua Taod,f,2, Edward M. De Robertisi,2, and Yi Dinga,b,2 aInstitute of Neuroscience, Translational Medicine Institute, Health Science Center, Xi’an Jiaotong University, 710061 Xi’an, China; bDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Health Science Center, Xi’an Jiaotong University, 710061 Xi’an, China; cKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, 310024 Hangzhou, China; dBeijing Advanced Innovation Center for Structural Biology, 100084 Beijing, China; eTsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, 100084 Beijing, China; fMinistry of Education (MOE) Key Laboratory of Protein Sciences, School of Life Sciences, Tsinghua University, 100084 Beijing, China; gDepartment of Nephrology, Xi’an Children’s Hospital, The Affiliated Children’s Hospital of Xi’an Jiaotong University, 710061 Xi’an, China; hDepartment of Orthodontics, College of Stomatology, Xi’an Jiaotong University, 710061 Xi’an, China; and iDepartment of Biological Chemistry, University of California, Los Angeles, CA 90095-1662 Contributed by Edward M. De Robertis, April 8, 2021 (sent for review January 7, 2021; reviewed by Enrique Amaya, Makoto Asashima, and Edgar M. Pera) Fibroblast growth factor (FGF)/extracellular signal-regulated ki- processes during vertebrate early embryogenesis, including gas- nase (ERK) signaling plays a crucial role in anterior–posterior trulation, mesoderm formation, and A–P axis specification (6).
[Show full text]
Engineered Chymotrypsin for Mass Spectrometry-Based Detection of Protein Glycosylation Balakrishnan Ramesh,†,§ Shaza Abnouf,†,§ Sujina Mali,‡ Wilna J
Articles Cite This: ACS Chem. Biol. 2019, 14, 2616−2628 pubs.acs.org/acschemicalbiology Engineered ChymotrypsiN for Mass Spectrometry-Based Detection of Protein Glycosylation Balakrishnan Ramesh,†,§ Shaza Abnouf,†,§ Sujina Mali,‡ Wilna J. Moree,‡ Ujwal Patil,‡ Steven J. Bark,‡ and Navin Varadarajan*,† † Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas 77204-4004, United States ‡ Department of Biology and Biochemistry, University of Houston, Houston, Texas 77004, United States *S Supporting Information ABSTRACT: We have engineered the substrate specificity of chymotrypsin to cleave after Asn by high-throughput screening of large libraries created by comprehensive remodeling of the substrate binding pocket. The engineered variant (chymotrypsiN, ChyB-Asn) demonstrated an altered substrate specificity with an expanded preference for Asn- containing substrates. We confirmed that protein engineering did not compromise the stability of the enzyme by biophysical characterization. Comparison of wild-type ChyB and ChyB- Asn in profiling lysates of HEK293 cells demonstrated both qualitative and quantitative differences in the nature of the peptides and proteins identified by liquid chromatography and tandem mass spectrometry. ChyB-Asn enabled the identi- fication of partially glycosylated Asn sites within a model glycoprotein and in the extracellular proteome of Jurkat T cells. ChymotrypsiN is a valuable addition to the toolkit of proteases to aid the mapping of N-linked glycosylation sites within proteins and
[Show full text]
The Genetic Architecture of Down Syndrome Phenotypes Revealed by High-Resolution Analysis of Human Segmental Trisomies
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies Jan O. Korbela,b,c,1, Tal Tirosh-Wagnerd,1, Alexander Eckehart Urbane,f,1, Xiao-Ning Chend, Maya Kasowskie, Li Daid, Fabian Grubertf, Chandra Erdmang, Michael C. Gaod, Ken Langeh,i, Eric M. Sobelh, Gillian M. Barlowd, Arthur S. Aylsworthj,k, Nancy J. Carpenterl, Robin Dawn Clarkm, Monika Y. Cohenn, Eric Dorano, Tzipora Falik-Zaccaip, Susan O. Lewinq, Ira T. Lotto, Barbara C. McGillivrayr, John B. Moeschlers, Mark J. Pettenatit, Siegfried M. Pueschelu, Kathleen W. Raoj,k,v, Lisa G. Shafferw, Mordechai Shohatx, Alexander J. Van Ripery, Dorothy Warburtonz,aa, Sherman Weissmanf, Mark B. Gersteina, Michael Snydera,e,2, and Julie R. Korenbergd,h,bb,2 Departments of aMolecular Biophysics and Biochemistry, eMolecular, Cellular, and Developmental Biology, and fGenetics, Yale University School of Medicine, New Haven, CT 06520; bEuropean Molecular Biology Laboratory, 69117 Heidelberg, Germany; cEuropean Molecular Biology Laboratory (EMBL) Outstation Hinxton, EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; dMedical Genetics Institute, Cedars–Sinai Medical Center, Los Angeles, CA 90048; gDepartment of Statistics, Yale University, New Haven, CT 06520; Departments of hHuman Genetics, and iBiomathematics, University of California, Los Angeles, CA 90095; Departments of jPediatrics and kGenetics, University of North Carolina, Chapel Hill, NC 27599; lCenter for Genetic Testing,
[Show full text]
Rodent Models in Down Syndrome Research: Impact and Future Opportunities Yann Herault, Jean M
Rodent models in Down syndrome research: impact and future opportunities Yann Herault, Jean M. Delabar, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Eugene Yu, Veronique Brault To cite this version: Yann Herault, Jean M. Delabar, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Eugene Yu, et al.. Rodent models in Down syndrome research: impact and future opportunities. Disease Models & Mechanisms, Cambridge Company of Biologists, 2017, 23 (3), pp.578-589. 10.1242/dmm.029728. hal-01626762 HAL Id: hal-01626762 https://hal.sorbonne-universite.fr/hal-01626762 Submitted on 31 Oct 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License © 2017. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2017) 10, 1165-1186 doi:10.1242/dmm.029728 REVIEW Rodent models in Down syndrome research: impact and future opportunities Yann Herault1,2,3,4,5,*, Jean M. Delabar5,6,7,8, Elizabeth M. C. Fisher5,9,10, Victor L. J. Tybulewicz5,10,11,12, Eugene Yu5,13,14 and Veronique Brault1,2,3,4 ABSTRACT significantly impairs health and autonomy of affected individuals Down syndrome is caused by trisomy of chromosome 21.
[Show full text]
Targeting Breakthroughs - Harnessing Cures October 9-12, 2014 • Grand Hyatt Shanghai • Pudong, Shanghai, P.R
New Horizons in Cancer Research: Targeting Breakthroughs - Harnessing Cures October 9-12, 2014 • Grand Hyatt Shanghai • Pudong, Shanghai, P.R. China Poster Session A – Friday, October 10, 2014, 12:30-3:00 p.m. A02 Therapeutic targeting of the histone demethylase KDM4 subfamily in breast cancer. Qin Ye, Andreana Holowatyj, Jack Wu, Hui Liu, Zeng-Quan Yang. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. Breast cancer is a heterogeneous disease, consisting of tumors with varying pathologic and molecular characteristics. The primary biological subtypes of breast cancer include estrogen receptor–positive (ER+) tumors (luminal A and B), tumors that are human epidermal growth factor receptor 2 (HER2) –enriched, and tumors that are ER/PR-negative (basal-like). These molecular determinants have significant effects on disease pathophysiology, clinical outcome, and treatment response. ER+ tumors are generally associated with better clinical prognosis, whereas basal-like tumors are associated with higher rates of metastasis and death. The treatment for basal breast cancer consists of standard chemotherapy regimens, as no effective molecularly targeted therapy has been developed. New therapeutic options are likely to result from a growing understanding of both genetic and epigenetic abnormalities that participate in the different types of breast cancer, which helps to identify new subtype-specific targets for therapy. Aberrant histone lysine methylation, controlled by histone lysine methyltransferases and demethylases, plays significant roles in cancer initiation and progression. Previously, we demonstrated that histone demethylase KDM4C (also known as GASC1 and JMJD2C) is significantly amplified and overexpressed in aggressive basal-type breast cancer. The KDM4C/GASC1 protein belongs to the KDM4 family of histone demethylases, in which KDM4A, B, and C share more than 50% percent of sequence identity.
[Show full text]
Morphology, Behavior, and the Sonic Hedgehog Pathway in Mouse Models of Down Syndrome
MORPHOLOGY, BEHAVIOR, AND THE SONIC HEDGEHOG PATHWAY IN MOUSE MODELS OF DOWN SYNDROME by Tara Dutka A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2014 © 2014 Tara Dutka All Rights Reserved Abstract Down Syndrome (DS) is caused by a triplication of human chromosome 21 (Hsa21). Ts65Dn, a mouse model of DS, contains a freely segregating extra chromosome consisting of the distal portion of mouse chromosome 16 (Mmu16), a region orthologous to part of Hsa21, and a non-Hsa21 orthologous region of mouse chromosome 17. All individuals with DS display some level of craniofacial dysmorphology, brain structural and functional changes, and cognitive impairment. Ts65Dn recapitulates these features of DS and aspects of each of these traits have been linked in Ts65Dn to a reduced response to Sonic Hedgehog (SHH) in trisomic cells. Dp(16)1Yey is a new mouse model of DS which has a direct duplication of the entire Hsa21 orthologous region of Mmu16. Dp(16)1Yey’s creators found similar behavioral deficits to those seen in Ts65Dn. We performed a quantitative investigation of the skull and brain of Dp(16)1Yey as compared to Ts65Dn and found that DS-like changes to brain and craniofacial morphology were similar in both models. Our results validate examination of the genetic basis for these phenotypes in Dp(16)1Yey mice and the genetic links for these phenotypes previously found in Ts65Dn , i.e., reduced response to SHH. Further, we hypothesized that if all trisomic cells show a reduced response to SHH, then up-regulation of the SHH pathway might ameliorate multiple phenotypes.
[Show full text]
Investigating Contributions of Trisomy 21 in Down Syndrome to Alzheimer Disease Phenotypes in a Novel Mouse Cross
Investigating contributions of trisomy 21 in Down syndrome to Alzheimer disease phenotypes in a novel mouse cross A thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy from University College London Xun Yu Choong Department of Neurodegenerative Disease Institute of Neurology University College London 2016 1 Declaration I, Xun Yu Choong, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Acknowledgements The work done in this project was only possible with the support of numerous friends and colleagues, with whom I have grown an incredible amount. Foremost thanks go to Prof. Elizabeth Fisher and Dr. Frances Wiseman, who have been inexhaustibly dedicated supervisors and inspirational figures. Special mention also goes to two unofficial mentors who have looked out for me throughout the PhD, Dr. Karen Cleverley and Dr. Sarah Mizielinska. The Fisher and Isaacs groups have been a joy to work with and have always unhesitatingly offered time and help. Thank you to the Down syndrome group: Olivia Sheppard, Dr. Toby Collins, Dr. Suzanna Noy, Amy Nick, Laura Pulford, Justin Tosh, Matthew Rickman; other members of Lizzy’s group: Dr. Anny Devoy, Dr. Rosie Bunton-Stasyshyn, Dr. Rachele Saccon, Julian Pietrzyk, Dr. Beverley Burke, Heesoon Park, Julian Jaeger; the Isaacs group: Dr. Adrian Isaacs, Dr. Emma Clayton, Dr. Roberto Simone, Charlotte Ridler, Frances Norona. The PhD office has also been a second home in more ways than one, thanks to: Angelos Armen, Dr.
[Show full text]
Cytokines Mapping for Tissue-Specific Expression, Eqtls and GWAS Traits
www.nature.com/scientificreports OPEN Cytokines mapping for tissue‑specifc expression, eQTLs and GWAS traits Lyubov E. Salnikova1,2*, Maryam B. Khadzhieva1,2, Dmitry S. Kolobkov1,3,4, Alesya S. Gracheva1,2, Artem N. Kuzovlev2 & Serikbay K. Abilev1 Dysregulation in cytokine production has been linked to the pathogenesis of various immune‑ mediated traits, in which genetic variability contributes to the etiopathogenesis. GWA studies have identifed many genetic variants in or near cytokine genes, nonetheless, the translation of these fndings into knowledge of functional determinants of complex traits remains a fundamental challenge. In this study we aimed at collection, analysis and interpretation of data on cytokines focused on their tissue‑specifc expression, eQTLs and GWAS traits. Using GO annotations, we generated a list of 314 cytokines and analyzed them with the GTEx resource. Cytokines were highly tissue‑specifc, 82.3% of cytokines had Tau expression metrics ≥ 0.8. In total, 3077 associations for 1760 unique SNPs in or near 244 cytokines were mapped in the NHGRI‑EBI GWAS Catalog. According to the Experimental Factor Ontology resource, the largest numbers of disease associations were related to ‘Infammatory disease’, ‘Immune system disease’ and ‘Asthma’. The GTEx‑based analysis revealed that among GWAS SNPs, 1142 SNPs had eQTL efects and infuenced expression levels of 999 eGenes, among them 178 cytokines. Several types of enrichment analysis showed that it was cytokines expression variability that fundamentally contributed to the molecular origins of considered immune-mediated conditions. Cytokines are regulatory proteins and glycoproteins that are synthesized and secreted by immune system cells and other cell types. Tey regulate innate and acquired immunity, embryogenesis, hematopoiesis, infammation and regeneration processes, and proliferation.
[Show full text]
Molecular Evolution During the Radiation of Caecilian Amphibians María Torres-Sánchez1,2* , David J
Torres-Sánchez et al. BMC Genomics (2019) 20:354 https://doi.org/10.1186/s12864-019-5694-1 RESEARCH ARTICLE Open Access What lies beneath? Molecular evolution during the radiation of caecilian amphibians María Torres-Sánchez1,2* , David J. Gower3, David Alvarez-Ponce4, Christopher J. Creevey5, Mark Wilkinson3 and Diego San Mauro1 Abstract Background: Evolution leaves an imprint in species through genetic change. At the molecular level, evolutionary changes can be explored by studying ratios of nucleotide substitutions. The interplay among molecular evolution, derived phenotypes, and ecological ranges can provide insights into adaptive radiations. Caecilians (order Gymnophiona), probably the least known of the major lineages of vertebrates, are limbless tropical amphibians, with adults of most species burrowing in soils (fossoriality). This enigmatic order of amphibians are very distinct phenotypically from other extant amphibians and likely from the ancestor of Lissamphibia, but little to nothing is known about the molecular changes underpinning their radiation. We hypothesised that colonization of various depths of tropical soils and of freshwater habitats presented new ecological opportunities to caecilians. Results: A total of 8540 candidate groups of orthologous genes from transcriptomic data of five species of caecilian amphibians and the genome of the frog Xenopus tropicalis were analysed in order to investigate the genetic machinery behind caecilian diversification. We found a total of 168 protein-coding genes with signatures of positive selection at different evolutionary times during the radiation of caecilians. The majority of these genes were related to functional elements of the cell membrane and extracellular matrix with expression in several different tissues. The first colonization of the tropical soils was connected to the largest number of protein-coding genes under positive selection in our analysis.
[Show full text]
Expression Changes Confirm Predicted Single Nucleotide Variants Affecting Mrna Splicing
bioRxiv preprint doi: https://doi.org/10.1101/549089; this version posted February 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Expression changes confirm predicted single nucleotide variants affecting mRNA splicing Eliseos J. Mucaki and Peter K. Rogan Departments of Biochemistry and Computer Science University of Western Ontario, London ON Correspondence: Peter K. Rogan, Ph.D. SDRI 201A, Schulich School of Medicine and Dentistry The University of Western Ontario London ON Canada N6A 5C1 E: [email protected] T: 519-661-4255 1 bioRxiv preprint doi: https://doi.org/10.1101/549089; this version posted February 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Mutations that cause genetic diseases can be difficult to identify if the mutation does not affect the sequence of the protein, but the splice form of the transcript. However, the prediction of deleterious changes caused by genomic variants that affect splicing has been shown to be accurate using information theory-based methods. We made several such predictions of potential splicing changes that could be caused by SNPs which were found to cause natural and/or cryptic splice site strength changes. We evaluated a selected set of 22 SNPs that we predicted by information analysis to affect splicing, validated these with targeted expression analysis, and compared the results with genome-scale interpretation of RNAseq data from tumors.
[Show full text]
Identification of Potential and Novel Target Genes in Pituitary Prolactinoma by Bioinformatics Analysis
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis 1 2 3 4* Vikrant Ghatnatti , Basavaraj Vastrad , Swetha Patil , Chanabasayya Vastrad , Iranna Kotturshetti5 1. Dept of Endocrinology/Medicine, J N Medical College, Belagavi 590010, Karnataka, India. 2. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 3. Dept of Obstetrics and Gynaecology, J N Medical college, Belagavi 590010, Karnataka, India. 4. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India. 5. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron 562209, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India Abstract bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Pituitary prolactinoma is one of the most complicated and fatally pathogenic pituitary adenomas. Therefore, there is an urgent need to improve our understanding of the underlying molecular mechanism that drives the initiation, progression, and metastasis of pituitary prolactinoma. The aim of the present study was to identify the key genes and signaling pathways associated with pituitary prolactinoma using bioinformatics analysis. Transcriptome microarray dataset GSE119063 was acquired from Gene Expression Omnibus datasets, which included 5 pituitary prolactinoma samples and 4 normal pituitaries samples.
[Show full text]